Alpha-1 Antitrypsin as a Regulatory Protease Inhibitor Modulating Inflammation and Shaping the Tumor Microenvironment...

Area of Science:

• Biochemistry
• Immunology
• Oncology

Background:

• Alpha-1 antitrypsin (AAT) is a primary serine protease inhibitor crucial for maintaining tissue integrity, particularly in the lungs.
• AAT deficiency is linked to chronic obstructive pulmonary disease due to unchecked protease activity.
• Recent studies indicate AAT's involvement in cancer-associated inflammation and tumor microenvironment modulation.

Purpose of the Study:

• To provide a comprehensive review of Alpha-1 antitrypsin's (AAT) multifaceted roles.
• To elucidate AAT's function in inflammation and the tumor microenvironment.
• To explore AAT's clinical implications in cancer diagnosis, prognosis, and therapy.

Main Methods:

• Literature review and synthesis of existing research on AAT.
• Analysis of AAT's structure, molecular properties, and functions.
• Examination of AAT's involvement in inflammatory responses and cancer.

Main Results:

• AAT plays a critical role in regulating inflammatory processes.
• AAT influences the dynamics of the tumor microenvironment.
• AAT has significant clinical implications for cancer patients.

Conclusions:

• AAT is an essential immune modulator with substantial potential in cancer immunotherapy.
• Bridging the understanding of AAT in inflammatory diseases and cancer is crucial.
• Further research into AAT's translational potential for cancer immunotherapy is warranted.